← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2015Last known activity
Apr 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 11 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT07050212Sponsor investigatorN/AApr 1, 2025
- NCT07050212Lead sponsorN/AApr 1, 2025
- NCT07050212OfficialN/AApr 1, 2025
- NCT06882980Lead sponsorN/AFeb 22, 2025
- NCT06882980OfficialN/AFeb 22, 2025
- NCT06882980Sponsor investigatorN/AFeb 22, 2025
- NCT06036797Lead sponsorPhase 2Sep 17, 2023
- NCT06036797Overall official - principal investigatorPhase 2Sep 17, 2023
- NCT06036797Reponsible party - principal investigatorPhase 2Sep 17, 2023
- NCT06633315Sponsor investigatorPhase 2Dec 1, 2022
- NCT06633315OfficialPhase 2Dec 1, 2022
- NCT06633315Lead sponsorPhase 2Dec 1, 2022
- NCT05635955Lead sponsorPhase 2Aug 1, 2022
- NCT05635955Overall official - principal investigatorPhase 2Aug 1, 2022
- NCT05635955Reponsible party - principal investigatorPhase 2Aug 1, 2022
Details
- Founded
- Wuhan, CN
- Last known activity
- Apr 1, 2025